Several regulators, one pharmacy
In New York, pharmacists are licensed and pharmacies registered through the State Education Department, with the Board of Pharmacy involved in standards and inspections and discipline handled through the department's professional discipline process. Controlled substances add a federal layer: the Drug Enforcement Administration issues registrations and can move to suspend or revoke one, in serious cases before a hearing is held. The state Department of Health runs the prescription monitoring program and controlled substance rules. Medicaid audits often come through the state's Medicaid inspector general, and pharmacy benefit managers run their own audits under network contracts. Pharmacy license defense often means dealing with more than one of these at the same time, and an issue raised by one tends to reach the others.
Records that matter most
Inventory and dispensing records usually sit at the center. Gather controlled substance inventories, ordering and receiving records, theft or loss reports, prescription files, and records showing how red flags on suspicious prescriptions were evaluated and resolved. If counts are off, find out whether the cause is recordkeeping, diversion by an employee, or something else, but do not hold back a required theft or loss report while you investigate; involve counsel promptly so the report is accurate. For audits, collect the signature logs, prescriber verification, and billing records for the claims in question. Do not alter or recreate records after the fact, since doing so can turn a recordkeeping issue into a far more serious one.
Coordinating the response
Each agency has its own deadlines, and some are short, especially when a registration or network status is at stake. We look first at which actions threaten immediate operations, such as a DEA registration problem or a network termination, and then at the licensing matter for the pharmacist in charge and the pharmacy itself. Responses should be consistent across agencies, because inconsistencies are noticed. We also review whether corrective steps such as new inventory controls or staff training should be in place before any meeting with regulators.
